| Rhythm control versus rate control for atrial fibrillation and heart failure D Roy, M Talajic, S Nattel, DG Wyse, P Dorian, KL Lee, MG Bourassa, ... New England Journal of Medicine 358 (25), 2667-2677, 2008 | 2096 | 2008 |
| Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction A Ducharme, S Frantz, M Aikawa, E Rabkin, M Lindsey, LE Rohde, ... The Journal of clinical investigation 106 (1), 55-62, 2000 | 1064 | 2000 |
| Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials E Vermes, JC Tardif, MG Bourassa, N Racine, S Levesque, M White, ... Circulation 107 (23), 2926-2931, 2003 | 879 | 2003 |
| 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ... Canadian Journal of Cardiology 33 (11), 1342-1433, 2017 | 788 | 2017 |
| Cystatin C deficiency in human atherosclerosis and aortic aneurysms GP Shi, GK Sukhova, A Grubb, A Ducharme, LH Rhode, RT Lee, ... The Journal of clinical investigation 104 (9), 1191-1197, 1999 | 682 | 1999 |
| Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure … LG Olsson, K Swedberg, A Ducharme, CB Granger, EL Michelson, ... Journal of the American College of Cardiology 47 (10), 1997-2004, 2006 | 666 | 2006 |
| Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice LE Rohde, A Ducharme, LH Arroyo, M Aikawa, GH Sukhova, ... Circulation 99 (23), 3063-3070, 1999 | 590 | 1999 |
| Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality … A Ducharme, K Swedberg, MA Pfeffer, A Cohen-Solal, CB Granger, ... American heart journal 152 (1), 86-92, 2006 | 543 | 2006 |
| Transmural action potential and ionic current remodeling in ventricles of failing canine hearts GR Li, CP Lau, A Ducharme, JC Tardif, S Nattel American Journal of Physiology-Heart and Circulatory Physiology 283 (3 …, 2002 | 339 | 2002 |
| Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) E Vermes, A Ducharme, MG Bourassa, M Lessard, M White, JC Tardif Circulation 107 (9), 1291-1296, 2003 | 334 | 2003 |
| The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure RS McKelvie, GW Moe, JA Ezekowitz, GA Heckman, J Costigan, ... Canadian Journal of Cardiology 29 (2), 168-181, 2013 | 287 | 2013 |
| Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction WT Abraham, MR Zile, FA Weaver, C Butter, A Ducharme, M Halbach, ... JACC: Heart Failure 3 (6), 487-496, 2015 | 282 | 2015 |
| Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial JA Lindenfeld, MR Zile, AS Desai, K Bhatt, A Ducharme, D Horstmanshof, ... The Lancet 398 (10304), 991-1001, 2021 | 273 | 2021 |
| Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation PL L'allier, A Ducharme, PF Keller, H Yu, MC Guertin, JC Tardif Journal of the American College of Cardiology 44 (1), 159-164, 2004 | 257 | 2004 |
| CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction M McDonald, S Virani, M Chan, A Ducharme, JA Ezekowitz, N Giannetti, ... Canadian Journal of Cardiology 37 (4), 531-546, 2021 | 250 | 2021 |
| Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial A Dore, C Houde, KL Chan, A Ducharme, P Khairy, M Juneau, F Marcotte, ... Circulation 112 (16), 2411-2416, 2005 | 239 | 2005 |
| Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation … JMO Arnold, JG Howlett, P Dorian, A Ducharme, N Giannetti, H Haddad, ... Canadian Journal of Cardiology 23 (1), 21-45, 2007 | 231 | 2007 |
| Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial A Ducharme, O Doyon, M White, JL Rouleau, JM Brophy Cmaj 173 (1), 40-45, 2005 | 222 | 2005 |
| The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care RS McKelvie, GW Moe, A Cheung, J Costigan, A Ducharme, ... Canadian journal of cardiology 27 (3), 319-338, 2011 | 200 | 2011 |
| Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction S Frantz, A Ducharme, D Sawyer, LE Rohde, L Kobzik, R Fukazawa, ... Journal of molecular and cellular cardiology 35 (6), 685-694, 2003 | 194 | 2003 |
